Clinical Trial

A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation

Study acronym: GreatPFA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of the study is to assess how well the standard ablation procedure (Varipulse Catheter) works over long term when used with different types of anesthesia in participants with symptomatic paroxysmal atrial fibrillation (PAF, irregular heartbeat that comes and goes on its own, causing noticeable symptoms like a racing heart, or shortness of breath).
Protocol Amendment History 3 changes
notable Primary completion pushed: 2028-02-09 -> 2028-07-28 2026-07-24
minor Completion pushed: 2028-03-28 -> 2028-07-28 2026-07-24
minor Completion pushed: 2028-02-09 -> 2028-03-28 2026-05-09
Trial Details
NCT Number NCT07511166
Lead Sponsor Johnson & Johnson Medical (Shanghai) Ltd.
Conditions Atrial Fibrillation
Enrollment 300 participants
Start Date 2026-09-07
Primary Completion 2028-07-28 (estimated)
Study Completion 2028-07-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-31